Thermodynamic profiling of conformationally constrained cyclic ligands for the PDZ domain

Bioorganic and Medicinal Chemistry Letters

Volumn 14, Issue 6, 2004, Pages 1385-1388

  Li, Tao ^a   Saro, Dorina ^a   Spaller, Mark R ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; PDZ PROTEIN; POSTSYNAPTIC DENSITY PROTEIN 95;

ARTICLE; BINDING AFFINITY; CALORIMETRY; DISSOCIATION CONSTANT; ISOTHERM; PROTEIN CONFORMATION; THERMODYNAMICS; TITRIMETRY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BINDING SITES; LIGANDS; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; PROTEIN CONFORMATION; THERMODYNAMICS;

EID: 1542285113     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2003.09.103     Document Type: Article

References (23)

1. Sheng M., Sala C. Ann. Rev. Neurosci. 24:2001;1.
2. Harris B.Z., Lim W.A. J. Cell. Sci. 114:2001;3219.
3. Pawson T., Scott J.D. Science. 278:1997;2075.
4. Kiyono T., Hiraiwa A., Fujita M., Hayashi Y., Akiyama T., Ishibashi M. Proc. Natl. Acad. Sci. U.S.A. 94:1997;11612.
5. Nguyen M.L., Nguyen M.M., Lee D., Griep A.E., Lambert P.F. J. Virol. 77:2003;6957.
6. Koo T.H., Lee J.J., Kim E.M., Kim K.W., Kim H.D., Lee J.H. Oncogene. 21:2002;4080.
7. Chaib H., Rubin M.A., Mucci N.R., Li L., Taylor J.M.G., Day M.L., Rhim J.S., Macoska J.A. Cancer Res. 61:2001;2390.
8. Dev K.K., van der Putten H., Sommer B., Rovelli G. Neuropharmacology. 45:2003;1.
9. Aarts M., Liu Y., Liu L., Besshoh S., Arundine M., Gurd J.W., Wang Y.T., Salter M.W., Tymianski M. Science. 298:2002;846.
10. Doyle D.A., Lee A., Lewis J., Kim E., Sheng M., MacKinnon R. Cell. 85:1996;1067.
11. Niethammer M., Valtschanoff J.G., Kapoor T.M., Allison D.W., Weinberg T.M., Craig A.M., Sheng M. Neuron. 20:1998;693.
12. Toniolo C. Int. J. Pept. Protein Res. 35:1990;287.
13. Gilon C., Halle D., Chorev M., Selinger Z., Byk G. Biopolymers. 31:1991;745.
14. Chhabra S.R., Khan A.N., Bycroft B.W. Tetrahedron Lett. 39:1998;3585.
15. Yue C., Thierry J., Potier P. Tetrahedron Lett. 34:1993;323.
16. Leavitt S., Freire E. Curr. Opin. Struct. Biol. 11:2001;560.
17. Ward W.H., Holdgate G.A. Prog. Med. Chem. 38:2001;309.
18. Songyang Z., Fanning A.S., Fu C., Xu J., Marfatia S.M., Chishti A.H., Crompton A., Chan A.C., Anderson J.M., Cantley L.C. Science. 275:1997;73.
19. Fuh G., Pisabarro M.T., Li Y., Quan C., Lasky L.A., Sidhu S.S. J. Biol. Chem. 275:2000;21486.
20. Harris B.Z., Hillier B.J., Lim W.A. Biochemistry. 40:2001;5921.
21. Novak K.A., Fujii N., Guy R.K. Bioorg. Med. Chem. Lett. 12:2002;2471.
22. Efficient Pip removal is critical, and on later occasions we found that 2-3% TFA is required. TFA levels were kept as low as possible to prevent partial release of the peptide from resin.
23. Analytical HPLC of the crude compounds showed minor peaks (attributed to multimers). Preparative HPLC that isolated the major peak in each case yielded the desired compound.